A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Fenproporex
Potassium perchlorate
Potassium perchlorate may increase the hyperkalemic activities of Candesartan.
Fenproporex
Dipotassium phosphate
Dipotassium phosphate may increase the hyperkalemic activities of Candesartan.
Fenproporex
Monopotassium phosphate
Monopotassium phosphate may increase the hyperkalemic activities of Candesartan.
Fenproporex
Potassium citrate
Potassium citrate may increase the hyperkalemic activities of Candesartan.
Fenproporex
Potassium alum
Potassium alum may increase the hyperkalemic activities of Candesartan.
Fenproporex
Potassium Iodide
Potassium Iodide may increase the hyperkalemic activities of Candesartan.
Fenproporex
Belantamab mafodotin
The excretion of Belantamab mafodotin can be decreased when combined with Candesartan.
Fenproporex
Remdesivir
The excretion of Remdesivir can be decreased when combined with Candesartan.
Fenproporex
Atrasentan
The excretion of Atrasentan can be decreased when combined with Candesartan.
Fenproporex
Barnidipine
Candesartan may increase the antihypertensive activities of Barnidipine.
Fenproporex
Quinoline Yellow WS
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinoline Yellow WS is combined with Candesartan.
Fenproporex
Quinaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinaprilat is combined with Candesartan.
Fenproporex
Perindoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Perindoprilat is combined with Candesartan.
Fenproporex
Moexiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Moexiprilat is combined with Candesartan.
Fenproporex
Trandolaprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Trandolaprilat is combined with Candesartan.
Fenproporex
Ramiprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Ramiprilat is combined with Candesartan.
Fenproporex
Fosinoprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Fosinoprilat is combined with Candesartan.
Fenproporex
Benazeprilat
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Benazeprilat is combined with Candesartan.
Fenproporex
Delapril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Delapril is combined with Candesartan.
Fenproporex
Zofenopril
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Candesartan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3